CSIMarket
 


Stemline Therapeutics Inc  (STML)
Other Ticker:  
 

Stemline Therapeutics Inc's Working Capital Ratio

STML's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




STML Working Capital Ratio (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Current Liabilities Change 29.49 % 46.55 % 35.01 % 6.96 % 19.84 %
Y / Y Current Assets Change 144.01 % 28.33 % 33.13 % 20.83 % 21.79 %
Working Capital Ratio MRQ 8.75 4.71 5.07 2.97 4.65
Overall Ranking # # # # #
Seq. Current Liabilities Change -16.23 % 1.34 % 24.62 % 22.4 % -5.2 %
Seq. Current Assets Change 55.67 % -5.76 % 112.41 % -21.7 % -18.13 %



Working Capital Ratio third quarter 2019 Comment
Stemline Therapeutics Inc's Current Assets grew by 55.67 % in III. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Stemline Therapeutics Inc's Working Capital Ratio to 8.75, Working Capital Ratio remained below Stemline Therapeutics Inc average.

Within Major Pharmaceutical Preparations industry 63 other companies have achieved higher Working Capital Ratio than Stemline Therapeutics Inc in third quarter 2019. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is STML most successful ?
Working Capital Ratio STML on the trailing twelve month basis
Working Capital Ratio third quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 64
Healthcare Sector # 128
Overall Market # 403


Working Capital Ratio Statistics
High Average Low
31.09 8.63 2.63
(Sep 30 2013)   (Dec 31 2017)




Financial Statements
Stemline Therapeutics Inc's Current Liabilities $ 22 Millions Visit STML's Balance sheet
Stemline Therapeutics Inc's Current Assets $ 197 Millions Visit STML's Balance sheet
Source of STML's Sales Visit STML's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingSep 30 2019, within Major Pharmaceutical Preparations Industry Working Capital RatioSep 30 2019 MRQ Current AssetsSep 30 2019 MRQ Current Liabilities
Phasebio Pharmaceuticals Inc  22.85 $ 83.369  Millions$ 3.649  Millions
Xbiotech Inc.  20.24 $ 40.911  Millions$ 2.021  Millions
Seres Therapeutics, Inc.  20.11 $ 89.578  Millions$ 4.455  Millions
Cassava Sciences Inc  20.05 $ 18.189  Millions$ 0.907  Millions
Kura Oncology, Inc.  19.66 $ 252.948  Millions$ 12.865  Millions
Principia Biopharma Inc.  18.03 $ 152.362  Millions$ 8.449  Millions
Enanta Pharmaceuticals, Inc  17.77 $ 401.848  Millions$ 22.609  Millions
Crinetics Pharmaceuticals, Inc.  17.18 $ 135.404  Millions$ 7.882  Millions
Magenta Therapeutics, Inc.  17.16 $ 165.230  Millions$ 9.629  Millions
Verrica Pharmaceuticals Inc.  17.10 $ 74.040  Millions$ 4.330  Millions
Marker Therapeutics, Inc.  16.90 $ 50.484  Millions$ 2.988  Millions
Glycomimetics Inc  16.75 $ 174.849  Millions$ 10.436  Millions
Allogene Therapeutics, Inc.  15.28 $ 509.757  Millions$ 33.354  Millions
Global Blood Therapeutics, Inc.  14.95 $ 615.803  Millions$ 41.193  Millions
Geron Corp  13.79 $ 142.121  Millions$ 10.305  Millions
Guardion Health Sciences, Inc.  13.36 $ 6.132  Millions$ 0.459  Millions
Mirati Therapeutics, Inc.  13.15 $ 464.648  Millions$ 35.336  Millions
Savara Inc.  13.07 $ 108.346  Millions$ 8.291  Millions
Nucana Plc  13.05 $ 71.282  Millions$ 5.463  Millions
Prothena Corp Plc  12.88 $ 409.202  Millions$ 31.763  Millions
Synlogic, Inc.  12.70 $ 131.319  Millions$ 10.337  Millions
Aravive, Inc.  12.36 $ 48.468  Millions$ 3.921  Millions
Prophase Labs, Inc.  12.32 $ 13.219  Millions$ 1.073  Millions
Adial Pharmaceuticals, Inc.  12.23 $ 9.501  Millions$ 0.777  Millions
Spring Bank Pharmaceuticals, Inc.  12.18 $ 64.876  Millions$ 5.327  Millions
Dermira, Inc.  12.04 $ 412.519  Millions$ 34.273  Millions
Albireo Pharma, Inc.  12.01 $ 148.019  Millions$ 12.327  Millions
Rocket Pharmaceuticals, Inc.  11.56 $ 245.591  Millions$ 21.246  Millions
Hepion Pharmaceuticals, Inc.  11.56 $ 15.185  Millions$ 1.314  Millions
Agile Therapeutics Inc  11.47 $ 19.686  Millions$ 1.717  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MICT's Profile

Stock Price

MICT's Financials

Business Description

Fundamentals

Charts & Quotes

MICT's News

Suppliers

MICT's Competitors

Customers & Markets

Economic Indicators

MICT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071